vs
EchoStar CORP（SATS）与Stryker Corporation（SYK）财务数据对比。点击上方公司名可切换其他公司
Stryker Corporation的季度营收约是EchoStar CORP的1.9倍（$7.2B vs $3.8B），Stryker Corporation净利率更高（11.8% vs -31.8%，领先43.6%），Stryker Corporation同比增速更快（11.4% vs -4.3%），Stryker Corporation自由现金流更多（$1.9B vs $-583.4M），过去两年Stryker Corporation的营收复合增速更高（16.9% vs -2.8%）
EchoStar Corp曾于2004年至2011年与TiVo公司发生专利纠纷，TiVo主张前者侵犯其DVR技术相关专利。该案先后由美国得克萨斯州东区联邦地区法院、联邦巡回上诉法院审理，涉及专利侵权判定、禁令条款、侵权产品改造、藐视法庭裁定及处罚等多个争议点。
斯特赖克是一款八轮装甲战车，衍生自加拿大LAV III步兵战车，而后者源自瑞士莫瓦格食人鱼系列装甲车。该型战车由加拿大通用动力陆地系统公司为美国陆军生产，制造工厂位于安大略省伦敦市。它默认采用8×4四轮驱动，可切换为8×8全轮驱动模式。
SATS vs SYK — 直观对比
营收规模更大
SYK
是对方的1.9倍
$3.8B
营收增速更快
SYK
高出15.7%
-4.3%
净利率更高
SYK
高出43.6%
-31.8%
自由现金流更多
SYK
多$2.5B
$-583.4M
两年增速更快
SYK
近两年复合增速
-2.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $3.8B | $7.2B |
| 净利润 | $-1.2B | $849.0M |
| 毛利率 | — | 64.5% |
| 营业利润率 | -20.5% | 25.2% |
| 净利率 | -31.8% | 11.8% |
| 营收同比 | -4.3% | 11.4% |
| 净利润同比 | -460.1% | 55.5% |
| 每股收益（稀释后） | $-4.27 | $2.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收SATSSYK
| Q4 25 | $3.8B | $7.2B | ||
| Q3 25 | $3.6B | $6.1B | ||
| Q2 25 | $3.7B | $6.0B | ||
| Q1 25 | $3.9B | $5.9B | ||
| Q4 24 | $4.0B | $6.4B | ||
| Q3 24 | $3.9B | $5.5B | ||
| Q2 24 | $4.0B | $5.4B | ||
| Q1 24 | $4.0B | $5.2B |
净利润SATSSYK
| Q4 25 | $-1.2B | $849.0M | ||
| Q3 25 | $-12.8B | $859.0M | ||
| Q2 25 | $-306.1M | $884.0M | ||
| Q1 25 | $-202.7M | $654.0M | ||
| Q4 24 | $335.2M | $546.0M | ||
| Q3 24 | $-141.8M | $834.0M | ||
| Q2 24 | $-205.6M | $825.0M | ||
| Q1 24 | $-107.4M | $788.0M |
毛利率SATSSYK
| Q4 25 | — | 64.5% | ||
| Q3 25 | — | 63.6% | ||
| Q2 25 | — | 63.8% | ||
| Q1 25 | — | 63.8% | ||
| Q4 24 | — | 64.9% | ||
| Q3 24 | — | 64.0% | ||
| Q2 24 | — | 63.0% | ||
| Q1 24 | — | 63.6% |
营业利润率SATSSYK
| Q4 25 | -20.5% | 25.2% | ||
| Q3 25 | -460.5% | 18.7% | ||
| Q2 25 | -5.7% | 18.5% | ||
| Q1 25 | -2.3% | 14.3% | ||
| Q4 24 | -1.6% | 9.0% | ||
| Q3 24 | -4.1% | 19.7% | ||
| Q2 24 | -1.7% | 19.4% | ||
| Q1 24 | -0.4% | 18.5% |
净利率SATSSYK
| Q4 25 | -31.8% | 11.8% | ||
| Q3 25 | -353.6% | 14.2% | ||
| Q2 25 | -8.2% | 14.7% | ||
| Q1 25 | -5.2% | 11.1% | ||
| Q4 24 | 8.5% | 8.5% | ||
| Q3 24 | -3.6% | 15.2% | ||
| Q2 24 | -5.2% | 15.2% | ||
| Q1 24 | -2.7% | 15.0% |
每股收益（稀释后）SATSSYK
| Q4 25 | $-4.27 | $2.20 | ||
| Q3 25 | $-44.37 | $2.22 | ||
| Q2 25 | $-1.06 | $2.29 | ||
| Q1 25 | $-0.71 | $1.69 | ||
| Q4 24 | $1.24 | $1.41 | ||
| Q3 24 | $-0.52 | $2.16 | ||
| Q2 24 | $-0.76 | $2.14 | ||
| Q1 24 | $-0.40 | $2.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.0B | $4.0B |
| 总债务越低越好 | $18.7B | — |
| 股东权益账面价值 | $5.8B | $22.4B |
| 总资产 | $43.0B | $47.8B |
| 负债/权益比越低杠杆越低 | 3.24× | — |
8季度趋势，按日历期对齐
现金及短期投资SATSSYK
| Q4 25 | $3.0B | $4.0B | ||
| Q3 25 | $3.9B | $3.3B | ||
| Q2 25 | $4.3B | $2.4B | ||
| Q1 25 | $5.1B | $2.3B | ||
| Q4 24 | $5.5B | $3.7B | ||
| Q3 24 | $674.4M | $3.9B | ||
| Q2 24 | $520.6M | $1.9B | ||
| Q1 24 | $766.4M | $2.3B |
总债务SATSSYK
| Q4 25 | $18.7B | — | ||
| Q3 25 | $21.8B | — | ||
| Q2 25 | $25.4B | — | ||
| Q1 25 | $25.3B | — | ||
| Q4 24 | $25.7B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $951.0M | — |
股东权益SATSSYK
| Q4 25 | $5.8B | $22.4B | ||
| Q3 25 | $7.0B | $21.8B | ||
| Q2 25 | $19.7B | $21.2B | ||
| Q1 25 | $20.0B | $20.9B | ||
| Q4 24 | $20.2B | $20.6B | ||
| Q3 24 | $19.4B | $20.1B | ||
| Q2 24 | $19.6B | $19.8B | ||
| Q1 24 | $19.8B | $19.2B |
总资产SATSSYK
| Q4 25 | $43.0B | $47.8B | ||
| Q3 25 | $45.3B | $47.1B | ||
| Q2 25 | $59.9B | $46.3B | ||
| Q1 25 | $60.6B | $46.0B | ||
| Q4 24 | $60.9B | $43.0B | ||
| Q3 24 | $57.5B | $43.8B | ||
| Q2 24 | $55.3B | $39.1B | ||
| Q1 24 | $55.6B | $39.4B |
负债/权益比SATSSYK
| Q4 25 | 3.24× | — | ||
| Q3 25 | 3.13× | — | ||
| Q2 25 | 1.29× | — | ||
| Q1 25 | 1.27× | — | ||
| Q4 24 | 1.27× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.05× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-425.3M | $2.1B |
| 自由现金流经营现金流 - 资本支出 | $-583.4M | $1.9B |
| 自由现金流率自由现金流/营收 | -15.4% | 26.1% |
| 资本支出强度资本支出/营收 | 4.2% | 3.7% |
| 现金转化率经营现金流/净利润 | — | 2.52× |
| 过去12个月自由现金流最近4个季度 | $-1.1B | $4.3B |
8季度趋势，按日历期对齐
经营现金流SATSSYK
| Q4 25 | $-425.3M | $2.1B | ||
| Q3 25 | $111.7M | $1.5B | ||
| Q2 25 | $7.5M | $1.1B | ||
| Q1 25 | $206.8M | $250.0M | ||
| Q4 24 | $45.6M | $1.9B | ||
| Q3 24 | $276.2M | $1.5B | ||
| Q2 24 | $479.7M | $633.0M | ||
| Q1 24 | $451.3M | $204.0M |
自由现金流SATSSYK
| Q4 25 | $-583.4M | $1.9B | ||
| Q3 25 | $-144.4M | $1.4B | ||
| Q2 25 | $-285.7M | $928.0M | ||
| Q1 25 | $-51.7M | $127.0M | ||
| Q4 24 | $-298.7M | $1.7B | ||
| Q3 24 | $-57.5M | $1.3B | ||
| Q2 24 | $132.4M | $481.0M | ||
| Q1 24 | $-68.4M | $37.0M |
自由现金流率SATSSYK
| Q4 25 | -15.4% | 26.1% | ||
| Q3 25 | -4.0% | 22.3% | ||
| Q2 25 | -7.7% | 15.4% | ||
| Q1 25 | -1.3% | 2.2% | ||
| Q4 24 | -7.5% | 25.9% | ||
| Q3 24 | -1.5% | 23.7% | ||
| Q2 24 | 3.3% | 8.9% | ||
| Q1 24 | -1.7% | 0.7% |
资本支出强度SATSSYK
| Q4 25 | 4.2% | 3.7% | ||
| Q3 25 | 7.1% | 3.1% | ||
| Q2 25 | 7.9% | 3.0% | ||
| Q1 25 | 6.7% | 2.1% | ||
| Q4 24 | 8.7% | 4.1% | ||
| Q3 24 | 8.6% | 3.1% | ||
| Q2 24 | 8.8% | 2.8% | ||
| Q1 24 | 12.9% | 3.2% |
现金转化率SATSSYK
| Q4 25 | — | 2.52× | ||
| Q3 25 | — | 1.79× | ||
| Q2 25 | — | 1.26× | ||
| Q1 25 | — | 0.38× | ||
| Q4 24 | 0.14× | 3.54× | ||
| Q3 24 | — | 1.77× | ||
| Q2 24 | — | 0.77× | ||
| Q1 24 | — | 0.26× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
SATS
| Pay Tv | $2.4B | 62% |
| Wireless Services And Related Revenue | $846.5M | 22% |
| Equipment Sales And Other Revenue | $346.5M | 9% |
| Broadband And Satellite Services And Other Revenue | $264.1M | 7% |
SYK
| Medical | $1.3B | 18% |
| Endoscopy | $1.1B | 16% |
| Traumaand Extremities | $1.1B | 15% |
| Instruments | $925.0M | 13% |
| Knees | $749.0M | 10% |
| Neuro Cranial | $669.0M | 9% |
| Neurovascular | $539.0M | 8% |
| Hips | $499.0M | 7% |
| Other Orthopaedics | $267.0M | 4% |
| Spine | $8.0M | 0% |
